scholarly journals Molecular basis for allosteric regulation of the type 2 ryanodine receptor channel gating by key modulators

2019 ◽  
Author(s):  
Ximin Chi ◽  
Deshun Gong ◽  
Kang Ren ◽  
Gewei Zhou ◽  
Gaoxingyu Huang ◽  
...  

AbstractThe type-2 ryanodine receptor (RyR2) is responsible for releasing Ca2+ from the sarcoplasmic reticulum of cardiomyocytes, subsequently leading to muscle contraction. Here, we report four cryo-EM structures of porcine RyR2 bound to distinct modulators that collectively provide mechanistic insight into RyR2 regulation. Ca2+ alone induces a contraction of the Central domain that facilitates the dilation of S6 bundle, but is insufficient to open the pore. The small molecule agonist PCB95 helps Ca2+ to overcome the barrier for opening. FKBP12.6 induces a relaxation of the Central domain that decouples it from the S6 bundle, stabilizing RyR2 in a closed state. Caffeine locks the Central domain in a constitutively contracted state, while further addition of ATP opens the channel by strengthening the coupling between the U-motif and S6. Our study marks an important step towards mechanistic understanding of the complicated regulation of this key channel whose aberrant activity engenders life-threatening cardiac disorders.

2019 ◽  
Vol 116 (51) ◽  
pp. 25575-25582 ◽  
Author(s):  
Ximin Chi ◽  
Deshun Gong ◽  
Kang Ren ◽  
Gewei Zhou ◽  
Gaoxingyu Huang ◽  
...  

The type 2 ryanodine receptor (RyR2) is responsible for releasing Ca2+from the sarcoplasmic reticulum of cardiomyocytes, subsequently leading to muscle contraction. Here, we report 4 cryo-electron microscopy (cryo-EM) structures of porcine RyR2 bound to distinct modulators that, together with our published structures, provide mechanistic insight into RyR2 regulation. Ca2+alone induces a contraction of the central domain that facilitates the dilation of the S6 bundle but is insufficient to open the pore. The small-molecule agonist PCB95 helps Ca2+to overcome the barrier for opening. FKBP12.6 induces a relaxation of the central domain that decouples it from the S6 bundle, stabilizing RyR2 in a closed state even in the presence of Ca2+and PCB95. Although the channel is open when PCB95 is replaced by caffeine and adenosine 5′-triphosphate (ATP), neither of the modulators alone can sufficiently counter the antagonistic effect to open the channel. Our study marks an important step toward mechanistic understanding of the sophisticated regulation of this key channel whose aberrant activity engenders life-threatening cardiac disorders.


Metabolism ◽  
2021 ◽  
Vol 116 ◽  
pp. 154646
Author(s):  
R.A. Mosa ◽  
S.E. Mabhida ◽  
N.F. Sangweni ◽  
P.V. Dludla ◽  
A.R. Opoku ◽  
...  

1990 ◽  
Vol 58 (2) ◽  
pp. 471-481 ◽  
Author(s):  
H.H. Valdivia ◽  
C. Valdivia ◽  
J. Ma ◽  
R. Coronado

2016 ◽  
Vol 2016 ◽  
pp. 1-8 ◽  
Author(s):  
Francesca Galati ◽  
Antonio Galati ◽  
Serafina Massari

Ventricular arrhythmias are one of the most common causes of death in developed countries. The use of implantable cardiac defibrillators is the most effective treatment to prevent sudden cardiac death. To date, the ejection fraction is the only approved clinical variable used to determine suitability for defibrillator placement in subjects with heart failure. The purpose of this study was to assess whether genetic polymorphisms found in the ryanodine receptor type 2 (Q2958R) and histidine-rich calcium-binding protein (S96A) might serve as markers for arrhythmias. Genotyping was performed in 235 patients treated with defibrillator for primary and secondary prevention of arrhythmias. No significant association was found between the S96A polymorphism and arrhythmia onset, whereas the QQ2958 genotype in the ryanodine receptor gene was correlated with an increased risk of life-threatening arrhythmias. Concurrent stressor conditions, such as hypertension, seem to increase this effect. Our findings might help to better identify patients who could benefit from defibrillator implantation.


FEBS Letters ◽  
2001 ◽  
Vol 505 (3) ◽  
pp. 419-425 ◽  
Author(s):  
Thomas Böhle ◽  
Mathias C. Brandt ◽  
Nadine Henn ◽  
Annette Schmidt ◽  
Wilhelm Bloch ◽  
...  

2013 ◽  
Vol 425 (10) ◽  
pp. 1765-1781 ◽  
Author(s):  
Jae Sun Jeong ◽  
Annalisa Ansaloni ◽  
Raffaele Mezzenga ◽  
Hilal A. Lashuel ◽  
Giovanni Dietler

2013 ◽  
Vol 24 (4) ◽  
pp. 741-744 ◽  
Author(s):  
Wolfgang Lawrenz ◽  
Otto N. Krogmann ◽  
Marcus Wieczorek

AbstractCatecholaminergic polymorphic ventricular tachycardia is a rare life-threatening arrhythmogenic disorder. An association with paroxysmal atrial fibrillation and other atrial arrhythmias has been described, but in all published cases the initial manifestation of the disease was ventricular arrhythmia. This is the first report about a patient who presented with complex atrial tachycardia and sinus node dysfunction about 1 year before the typical ventricular arrhythmias were observed, leading to the diagnosis of catecholaminergic polymorphic ventricular tachycardia. In this girl, a mutation of the ryanodine receptor type 2 gene, which has not been described so far, was discovered.


2001 ◽  
Vol 287 (3) ◽  
pp. 696-700 ◽  
Author(s):  
Miklós Csala ◽  
Rosella Fulceri ◽  
József Mandl ◽  
Angelo Benedetti ◽  
Gábor Bánhegyi

Sign in / Sign up

Export Citation Format

Share Document